Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4635478
Max Phase: Preclinical
Molecular Formula: C19H21F3N6OS
Molecular Weight: 438.48
Molecule Type: Unknown
Associated Items:
ID: ALA4635478
Max Phase: Preclinical
Molecular Formula: C19H21F3N6OS
Molecular Weight: 438.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(N2C[C@H]3CC[C@@H](C2)[C@@H]3Nc2nc3c(OCC(F)(F)F)cccn3n2)sn1
Standard InChI: InChI=1S/C19H21F3N6OS/c1-11-7-15(30-26-11)27-8-12-4-5-13(9-27)16(12)23-18-24-17-14(29-10-19(20,21)22)3-2-6-28(17)25-18/h2-3,6-7,12-13,16H,4-5,8-10H2,1H3,(H,23,25)/t12-,13+,16-
Standard InChI Key: YKVXIQFXZBXIMS-YWVIFJGQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 438.48 | Molecular Weight (Monoisotopic): 438.1450 | AlogP: 3.76 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.58 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.69 | CX Basic pKa: 4.66 | CX LogP: 3.79 | CX LogD: 3.79 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.65 | Np Likeness Score: -1.51 |
1. Rodríguez Sarmiento RM, Bissantz C, Bylund J, Limberg A, Neidhart W, Jakob-Roetne R, Wang L, Baumann K.. (2020) Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring Bioisostere., 63 (15): [PMID:32706964] [10.1021/acs.jmedchem.0c00909] |
Source(1):